Concepedia

Publication | Open Access

The Significance of Early Alpha-Fetoprotein Level Changes in Predicting Clinical and Survival Benefits in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

DOIFull Paper Access

108

Citations

17

References

2011

Year

Thomas Yau, Tzy‐Jyun Yao, Pierre Chan, Hilda Wong, Roberta Pang, Sheung Tat Fan, Ronnie T.P. Poon
The Oncologist

Abstract

Drop in AFP level at 6 weeks is an exploratory early surrogate for both CB and PFS in advanced HCC patients receiving sorafenib.

References

YearCitations

Page 1